Pharmacogenomics of Cardiovascular Drugs for Atherothrombotic, Thromboembolic and Atherosclerotic Risk

Purpose of Review: Advances in pharmacogenomics have paved the way for personalized medicine. Cardiovascular diseases still represent the leading cause of mortality in the world. The aim of this review is to summarize the background, rationale, and evidence of pharmacogenomics in cardiovascular medi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mauriello, Alfredo, Ascrizzi, Antonia, Molinari, Riccardo, Falco, Luigi, Caturano, Alfredo, D’Andrea, Antonello, Russo, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671139/
https://www.ncbi.nlm.nih.gov/pubmed/38003001
http://dx.doi.org/10.3390/genes14112057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671139/
https://www.ncbi.nlm.nih.gov/pubmed/38003001
http://dx.doi.org/10.3390/genes14112057

Ejemplares similares